Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCI699 in Resistant Hypertension
NCT00817635Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of osilodrostat in resistant hypertension (RH), sponsored by Novartis. Started Dec 2008; status: completed.
02
Drugs
osilodrostat
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT00817635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817635.